Related Experiment Video
Updated: May 13, 2026
10:58
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Germinomas and Non-germinomatous Germ Cell Tumors
1Institut d'Hemato-Oncologie Pediatrique, Lyon, France. cecile.conter@ihope.fr.
Advances and Technical Standards in Neurosurgery
|May 11, 2026
Summary
Intracranial germ cell tumors (iGCTs) are rare pediatric brain tumors. Treatment and prognosis vary significantly between germinomas and non-germinomatous germ cell tumors (NGGCTs).
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Tumor Biology
Background:
- Intracranial germ cell tumors (iGCTs) are rare neoplasms affecting children and adolescents, primarily in the pineal and suprasellar regions.
- iGCTs constitute up to 20% of pediatric germ cell tumors, with a higher incidence observed in East Asian populations.
- These tumors are classified into germinomas and non-germinomatous germ cell tumors (NGGCTs), with germinomas representing two-thirds of cases.
Purpose of the Study:
- To review the classification, diagnosis, and treatment strategies for intracranial germ cell tumors.
- To highlight the differences in therapeutic approaches and prognoses between germinomas and NGGCTs.
- To emphasize the importance of accurate diagnosis and risk-adapted therapy for optimizing patient outcomes.
Main Methods:
- Classification based on histopathology and immunohistochemistry (SALL4, PLAP, OCT3/4, CD117).
- Diagnosis aided by imaging, tumor markers (AFP, beta-hCG), and sometimes biopsy.
- Treatment strategies tailored to tumor type: chemotherapy and radiotherapy for germinomas; intensive chemotherapy, surgery, and radiotherapy for NGGCTs.
Main Results:
- Germinomas are highly radiosensitive with an excellent prognosis.
- NGGCTs, including embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratomas, have a more guarded prognosis.
- Tumor markers like AFP and beta-hCG can guide diagnosis and treatment for NGGCTs, potentially obviating the need for biopsy.
Conclusions:
- Accurate diagnosis of iGCTs using imaging, markers, and histology is critical for effective management.
- Risk-adapted therapy is essential for optimizing outcomes in this heterogeneous group of CNS tumors.
- Long-term follow-up is crucial due to the risk of recurrence and treatment-related sequelae in iGCT patients.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...